|
[1]
|
Bass, M. (2007) Medical Treatment of Non-Alcoholic Steatohepatitis. Clinics in Liver Disease, 11, 119-140.
|
|
[2]
|
Welsh, J.A., Karpen, S. and Vos, M.B. (2013) Increasing Prevalence of Nonalcoholic Fatty Liver Disease among United States Adolescents, 1988-1994 to 2007-2010. The Journal of Pediatrics, 162, 496-500.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kojima, S., Watanabe, N., Numata, M., Ogawa, T. and Matsuzaki, S. (2003) Increase in the Prevalence of Fatty Liver in Japan over the Past 12 Years: Analysis of Clinical Background. Journal of Gastroenterology, 38, 954-961. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Szczepaniak, L.S., et al. (2005) Magnetic Resonance Spectrosco-py to Measure Hepatic Triglyceride Content: Prevalence of Hepatic Steatosis in the General Population. American Jour-nal of Physiology-Endocrinology and Metabolism, 288, E462-E468. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Williams, C.D., et al. (2011) Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study. Gastroenterology, 140, 124-131. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zhang, X.Q., Xu, C.F., Yu, C.H., Chen, W.X. and Li, Y.M. (2014) Role of Endoplasmic Reticulum Stress in the Pathogenesis of Nonalcoholic Fatty Liver Disease. World Journal of Gastroenterology 20, 1768-1776. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Hui, A.Y., et al. (2005) Histological Progression of Non-Alcoholic Fatty Liver Disease in Chinese Patients. Alimentary Pharmacology & Therapeutics, 21, 407-413. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Harrison, S.A., Torgerson, S. and Hayashi, P.H. (2003) The Natural History of Nonalcoholic Fatty Liver Disease: A Clinical Histopathological Study. The American Journal of Gastroenterology, 98, 2042-2047. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Jung, U.J. and Choi, M.S. (2014) Obesity and Its Meta-bolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 15, 6184-6223. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kershaw, E.E. and Flier, J.S. (2004) Adipose Tissue as an Endocrine Organ. The Journal of Clinical Endocrinology & Metabolism, 89, 2548-2556. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, Y., Rimm, E.B., Stampfer, M.J., Willett, W.C. and Hu, F.B. (2005) Comparison of Abdominal Adiposity and Overall Obesity in Predicting Risk of Type 2 Diabetes among Men. The American Journal of Clinical Nutrition, 81, 555-563. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Boden, G. (1997) Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM. Diabetes, 46, 3-10. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Suganami, T., Nishida, J. and Ogawa, Y. (2005) A Paracrine Loop be-tween Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor Alpha. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2062-2068. [Google Scholar] [CrossRef]
|
|
[14]
|
Skurk, T., Alberti-Huber, C., Herder, C. and Hauner, H. (2007) Relationship between Adipocyte Size and Adipokine Expression and Secretion. The Journal of Clinical Endo-crinology & Metabolism, 92, 1023-1033. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Rotter, V., Nagaev, I. and Smith, U. (2003) Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, like IL-8 and Tumor Necrosis Factor-Alpha, Overexpressed in Human Fat Cells from Insulin-Resistant Subjects. Journal of Biological Chemistry, 278, 45777-45784. [Google Scholar] [CrossRef]
|
|
[16]
|
Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante Jr., A.W. (2003) Obesity Is Associated with Macrophage Accumulation in Adipose Tissue. Journal of Clinical Investigation, 112, 1796-1808. [Google Scholar] [CrossRef]
|
|
[17]
|
Angulo, P. (2006) NAFLD, Obesity, and Bariatric Surgery. Gastroen-terology, 130, 1848-1852. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Poordad, F.F. (2004) The Role of Leptin in NAFLD: Contender or Pretender? Journal of Clinical Gastroenterology, 38, 841-843. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Cao, Q., Mak, K.M., Ren, C. and Lieber, C.S. (2004) Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells: Respective Roles of the JAK/STAT and JAK-Mediated H2O2-Dependant MAPK Pathways. Journal of Biological Chemistry, 279, 4292-4304. [Google Scholar] [CrossRef]
|
|
[20]
|
Arner, P. (2005) Human Fat Cell Lipolysis: Biochemistry, Regula-tion and Clinical Role. Best Practice & Research Clinical Endocrinology & Metabolism, 19, 471-482. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., Jessurun, J., Boldt, M.D. and Parks, E.J. (2005) Sources of Fatty Acids Stored in Liver and Secreted via Lipoproteins in Patients with Nonalcoholic Fatty Liver Disease. Journal of Clinical Investigation, 115, 1343-1351. [Google Scholar] [CrossRef]
|
|
[22]
|
Holt, H.B., et al. (2006) Non-Esterified Fatty Acid Concentrations Are In-dependently Associated with Hepatic Steatosis in Obese Subjects. Diabetologia, 49, 141-148. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Fabbrini, E., Sullivan, S. and Klein, S. (2010) Obesity and Non-alcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications. Hepatology, 51, 679-689. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hwang, J.H., Stein, D.T., et al. (2007) Increased Intrahepatic Triglyceride Is Associated with Peripheral Insulin Resistance: In Vivo MR Imaging and Spectroscopy Studies. American Journal of Physiology-Endocrinology and Metabolism, 293, E1663-E1669. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Miquilena-Colina, M.E., et al. (2011) Hepatic Fatty Acid Trans-locase CD36 Upregulation Is Associated with Insulin Resistance, Hyperinsulinaemia and Increased Steatosis in Non-Alcoholic Steatohepatitis and Chronic Hepatitis C. Gut, 60, 1394-1402. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Sanders, F.W. and Griffin, J.L. (2016) De Novo Lipogenesis in the Liver in Health and Disease: More than Just a Shunting Yard for Glucose. Biological Reviews of the Cambridge Philo-sophical Society, 91, 452-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Lin, J., et al. (2005) Hyperlipidemic Effects of Dietary Saturated Fats Medi-ated through PGC-1beta Coactivation of SREBP. Cell, 120, 261-273. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Yu, J., Marsh, S., Hu, J., Feng, W. and Wu, C. (2016) The Patho-genesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background. Gastro-enterology Research and Practice, 2016, Article ID: 2862173. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Bays, H.E., et al. (2008) Pathogenic Potential of Adipose Tissue and Metabolic Consequences of Adipocyte Hypertrophy and Increased Visceral Adiposity. Expert Review of Cardiovascular Therapy, 6, 343-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Fan, J.G. and Cao, H.X. (2013) Role of Diet and Nutritional Man-agement in Non-Alcoholic Fatty Liver Disease. Journal of Gastroenterology and Hepatology, 28, 81-87. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Stienstra, R., et al. (2010) Kupffer Cells Promote Hepatic Steatosis via In-terleukin-1beta-Dependent Suppression of Peroxisome Proliferator-Activated Receptor Alpha Activity. Hepatology, 51, 511-522. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Miura, K., et al. (2010) Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1beta in Mice. Gastroenterology, 139, 323-334.e7. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Koo, S.H. (2013) Nonalcoholic Fatty Liver Disease: Molecular Mechanisms for the Hepatic Steatosis. Clinical and Molecular Hepatology, 19, 210-215. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Ginsberg, H.N. and Fisher, E.A. (2009) The Ever-Expanding Role of Degradation in the Regulation of Apolipoprotein B Metabolism. Journal of Lipid Research, 50, S162-S166. [Google Scholar] [CrossRef]
|
|
[35]
|
Browning, J.D., Cohen, J.C. and Hobbs, H.H. (2010) Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease. Hepatology, 52, 1189-1192. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Jenkins, C.M., Mancuso, D.J., Yan, W., Sims, H.F., Gibson, B. and Gross, R.W. (2004) Identification, Cloning, Expression, and Purification of Three Novel Human Calcium-Independent Phos-pholipase A2 Family Members Possessing Triacylglycerol Lipase and Acylglycerol Transacylase Activities. Journal of Biological Chemistry, 279, 48968-48975. [Google Scholar] [CrossRef]
|
|
[37]
|
Mensink, R.P., Zock, P.L., Kester, A.D. and Katan, M.B. (2003) Ef-fects of Dietary Fatty Acids and Carbohydrates on the Ratio of Serum Total to HDL Cholesterol and on Serum Lipids and Apolipoproteins: A Meta-Analysis of 60 Controlled Trials. The American Journal of Clinical Nutrition, 77, 1146-1155. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Grosso, G., et al. (2014) Mediterranean Diet and Cardio-vascular Risk Factors: A Systematic Review. Critical Reviews in Food Science and Nutrition, 54, 593-610. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Ascha, M.S., Hanouneh, I.A., Lopez, R., Tamimi, T.A., Feld-stein, A.F. and Zein, N.N. (2010) The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonal-coholic Steatohepatitis. Hepatology, 51, 1972-1978. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Vitaglione, P., et al. (2010) Coffee Reduces Liver Damage in a Rat Model of Steatohepatitis: The Underlying Mechanisms and the Role of Polyphenols and Melanoidins. Hepatology, 52, 1652-1661. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Salomone, F., et al. (2014) Coffee Enhances the Expression of Chaperones and Antioxidant Proteins in Rats with Nonalcoholic Fatty Liver Disease. Translational Research, 163, 593-602. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Shi, H., et al. (2013) Effect of Chlorogenic Acid on LPS-Induced Proinflammatory Signaling in Hepatic Stellate Cells. Inflammation Research, 62, 581-587. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Chan, R., et al. (2015) Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy. PLOS ONE, 10, e0139310. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Kitson, M.T., Pham, A., Gordon, A., Kemp, W. and Roberts, S.K. (2016) High-Dose Vitamin D Supplementation and Liver Histology in NASH. Gut, 65, 717-718. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Ryu, S., et al. (2015) Relationship of Sitting Time and Physical Activity with Non-Alcoholic Fatty Liver Disease. Journal of Hepatology, 63, 1229-1237. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Thoma, C., Day, C.P. and Trenell, M.I. (2012) Lifestyle Interven-tions for the Treatment of Non-Alcoholic Fatty Liver Disease in Adults: A Systematic Review. Journal of Hepatology, 56, 255-266. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Jensen, M.D., et al. (2014) 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American College of Cardiology, 63, 2985-3023. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Uusitupa, M. (2016) Lifestyle Changes and Cardiovascular Risk Reduction in Diabetes. The Lancet Diabetes & Endocrinology, 4, 877-878. [Google Scholar] [CrossRef]
|
|
[49]
|
Hannah Jr., W.N. and Harrison, S.A. (2016) Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences, 61, 1365-1374. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Luyckx, F.H., et al. (1998) Liver Abnormalities in Severely Obese Subjects: Effect of Drastic Weight Loss after Gastroplasty. International Journal of Obesity and Related Metabolic Disorders, 22, 222-226. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Weinsier, R.L., Wilson, L.J. and Lee, J. (1995) Medically Safe Rate of Weight Loss for the Treatment of Obesity: A Guideline Based on Risk of Gallstone Formation. The American Journal of Medicine, 98, 115-117. [Google Scholar] [CrossRef]
|
|
[52]
|
Loureiro, M.L. and Nayga Jr., R.M. (2006) Obesity, Weight Loss, and Physician’s Advice. Social Science & Medicine, 62, 2458-2468. [Google Scholar] [CrossRef]
|